Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 21, 2026 04:34 ET | Source: Research and Markets

Bispecific Antibody Market Landscape Report 2026: A Potential $60 Opportunity by 2031 - Insight on More than 550 Clinical Trials - Antibody Dosage, Patent, Price, Sales & Outlook

Dublin, April 21, 2026 (GLOBE NEWSWIRE) -- The "Bispecific Antibody Market Opportunity, Antibody Dosage, Patent, Price, Sales & Clinical Trials Outlook 2031" report has been added to ...
April 20, 2026 12:24 ET | Source: Research and Markets

Site Management Organization Market Report 2026-2035 with Insights by Therapeutic Area, Trial Phases, Clinical Trial Components, Type of Interventions and Region

Dublin, April 20, 2026 (GLOBE NEWSWIRE) -- The "Site Management Organization Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Therapeutic Area, Trial Phases, Clinical Trial...
February 10, 2026 04:06 ET | Source: Research and Markets

EZH2 Targeted Therapy Market Research 2026: Ipsen Leads With Tazverik, Hengrui and Pfizer Advance Next-Generation EZH2 Programs - Opportunities, Approved Drug Prices, Sales, Clinical Trials Insights

Dublin, Feb. 10, 2026 (GLOBE NEWSWIRE) -- The "EZH2 Targeted Therapy Market Opportunity, Approved Drug Price, Sales and Clinical Trials Insight 2026" report has been added to ...
July 30, 2025 06:49 ET | Source: Research and Markets

Cancer Photodynamic Therapy Market Report 2025: Global Photosensitizers Clinical Pipeline By Company, Indication & Phase

Dublin, July 30, 2025 (GLOBE NEWSWIRE) -- The "Global Cancer Photodynamic Therapy Market & Clinical Trial Insight 2030" has been added to ResearchAndMarkets.com's offering. Photodynamic...
July 29, 2025 04:06 ET | Source: Research and Markets

North America Clinical Trials Market Forecast and Company Analysis Report 2025-2033 Featuring ICON, Wuxi AppTec, SGS, Syneos Health, PRA Health Sciences, Pfizer, IQVIA, and Medpace

Dublin, July 29, 2025 (GLOBE NEWSWIRE) -- The "North America Clinical Trials Market Size and Forecast Report 2025-2033" report has been added to ResearchAndMarkets.com's offering.The North America...
May 22, 2025 07:53 ET | Source: Research and Markets

Targeted Alpha Therapy Market Research 2024-2028: Drugs Approval, Proprietary Technologies & Clinical Trials Insights - Xofigo Sets Global Standard for Advanced Prostate Cancer Treatment

Dublin, May 22, 2025 (GLOBE NEWSWIRE) -- The "Targeted Alpha Therapy Market Size, Drugs Approval, Proprietary Technologies & Clinical Trials Insight 2028" has been added to ...
May 22, 2025 07:42 ET | Source: Research and Markets

VISTA Inhibitor Clinical Trials Market Insights and Drug Development Opportunities Report 2025: Building on PD-1 and CTLA-4 Breakthroughs - First VISTA Inhibitor Drug Gets Nod by 2028

Dublin, May 22, 2025 (GLOBE NEWSWIRE) -- The "VISTA Inhibitor Clinical Trials, Drug Development Opportunities & Patent Insight 2025" report has been added to ResearchAndMarkets.com's offering. ...
February 10, 2025 10:23 ET | Source: Research and Markets

Automated Microbiological Testing: The Future of Healthcare Diagnostics with AI and PCR Innovations

Dublin, Feb. 10, 2025 (GLOBE NEWSWIRE) -- The "Automated and Rapid Microbiological Tests - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market...
January 28, 2025 05:44 ET | Source: Research and Markets

Over 15 CD39-Targeted Treatments in Clinical Trials, Market Opportunity Surges by 2025

Dublin, Jan. 28, 2025 (GLOBE NEWSWIRE) -- The "CD39 Targeted Therapies Clinical Trials, Therapeutic Approaches & Market Opportunity Insight 2025" report has been added to ...
December 16, 2024 10:53 ET | Source: Research and Markets

Targeted Alpha Therapy Market, Drugs Approval, Proprietary Technologies & Clinical Trials: 20+ Drugs of Targeted Alpha Therapy In Clinical Trials

Dublin, Dec. 16, 2024 (GLOBE NEWSWIRE) -- The "Targeted Alpha Therapy Market Size, Drugs Approval, Proprietary Technologies & Clinical Trials Insight 2028" report has been added to ...